1 citations
,
February 2002 in “Oncology Times” Intravenous arsenic is safe and effective for treating certain blood cancers.
March 2022 in “Oncology Times” Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.
February 2020 in “Oncology Times” Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.
October 2018 in “Oncology Times” Hair is important for aging and cancer treatment, affecting emotions, culture, and health.
September 2016 in “Oncology times” Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.
April 2016 in “Dermatology Times” Ginseng might help with energy, memory, aging, cancer, skin issues, and hair loss.
March 2016 in “Oncology Times” Insurers opposed ASCO's recommendation for a single cancer care pathway program.
April 2015 in “Urology Times eNews” There's not enough data on finasteride's sexual side effects.
March 2015 in “Oncology Times” Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.
June 2014 in “Dermatology Times E-News” An arthritis drug helped a person with severe hair loss regrow their hair.
April 2014 in “Dermatology Times” Saw palmetto berries might help with hair growth.
October 2013 in “Urology Times eNews” The FDA approved using Cialis with Proscar for better treatment options.
September 2013 in “Oncology Times” Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.
April 2012 in “Dermatology Times E-News” Finasteride must now warn about lasting sexual side effects.
March 2012 in “Dermatology Times E-News” Men with pattern baldness may have a higher risk of prostate issues.
February 2012 in “Dermatology Times E-News” Finasteride helps men grow more hair and lose less.
June 2011 in “Oncology times” Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.
June 2011 in “Oncology times” New treatments are making advanced prostate cancer management more complex but also more hopeful.
November 2010 in “Oncology Times” More research is needed on better diagnostics, survivorship, and the impact of genetic mutations in lung cancer.
August 2010 in “Oncology Times” Provenge extends prostate cancer survival by about 4 months.
June 2010 in “Urology times” Finasteride causes fewer sexual side effects than dutasteride in men with BPH.
November 2009 in “Oncology Times” New standards were created to make chemotherapy safer and improve cancer care.
March 2008 in “Oncology Times” Patient care should come before profit in medicine.
April 2007 in “Oncology Times” Chemoprevention is rarely used due to concerns about risks, side effects, and lack of clear guidelines.
February 2007 in “Oncology Times” Lung cancer biology differs between women and men, with women responding better to certain treatments.
February 2004 in “Oncology Times” Green tea extract and cycling hormone treatments may help treat advanced prostate cancer.
January 2004 in “Oncology Times” Cancer myths can harm treatment and prevention efforts.
August 2003 in “Oncology Times” The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.
March 2003 in “Oncology Times” Further research is needed to develop effective cancer prevention strategies.
February 2003 in “Dermatology Times” Pay attention to early warnings.